Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2004 1
2005 1
2008 1
2012 1
2020 1
2021 1
2022 2
2023 4
2024 90
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Similar articles for PMID: 39510584

101 results

Results by year

Filters applied: . Clear all
Page 1
PET-Based TheraP Eligibility and Outcomes of VISION-Eligible Patients with Metastatic Castration-Resistant Prostate Cancer Who Received 177Lu-PSMA-617: Importance of 18F-FDG-Avid Discordant Findings.
Demirci RA, Ghodsi A, Gulati R, Behnia S, Nelson PS, Cheng HH, Yezefski TA, Haffner MC, Hawley JE, Montgomery RB, Yu EY, Schweizer MT, Chen DL, Iravani A. Demirci RA, et al. J Nucl Med. 2025 Jan 3;66(1):47-53. doi: 10.2967/jnumed.124.268167. J Nucl Med. 2025. PMID: 39542703
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.
Wenzel M, Koll F, Hoeh B, Humke C, Reis H, Wild P, Steuber T, Graefen M, Tilki D, Sabet A, Gröner D, Chun FKH, Mandel P. Wenzel M, et al. JCO Precis Oncol. 2024 Dec;8:e2400645. doi: 10.1200/PO-24-00645. Epub 2024 Dec 6. JCO Precis Oncol. 2024. PMID: 39642328
Baseline Nodal Status on 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial.
Hofman MS, Kasivisvanathan V, Link E, Buteau J, Roberts MJ, Francis RJ, Tang C, Vela I, Thomas P, Rutherford N, Martin JM, Frydenberg M, Shakher R, Wong LM, Taubman K, Ting Lee S, Hsiao E, Roach P, Nottage M, Kirkwood I, Hayne D, Iravani A, Williams S, O'Brien J, Lawrentschuk N, Murphy DG. Hofman MS, et al. Eur Urol Oncol. 2024 Nov 28:S2588-9311(24)00251-7. doi: 10.1016/j.euo.2024.11.006. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39613566 Free article.
101 results